Back to results
US 4,046,917 AGranted
Method of treating migraine
AssigneeSandoz Ltd.
InventorGunter Scholtysik
Life of this patent
Estimating the term…
Abstract
The invention relates to a new use of 2,6-dichlorophenyl-acetylguanidine as an anti-migraine agent.
Claims4
A method of treating or preventing migraine in animals which comprises administering a therapeutically effective amount of the compound 2,6-dichlorophenyl-acetylguanidine to an animal in need of such treatment.
The method of claim 3, wherein the compound is administered at a daily dosage of from 2 to 20 mg.
Dependencies are inferred from the claim text.